← All indications
Suicidal Ideation
A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.
Drugs by status
Phase 4 trials (13)
Phase 3 trials (3)
Phase 2 trials (6)
Organizations
Organization Involved with Phase 4 Indications (15)
- National Institute of Mental Health (NIMH)
- Augusta University
- Harvard University
- Duke University
- Wake Forest University
- Columbia University
- Icahn School of Medicine at Mount Sinai
- University of North Carolina at Chapel Hill
- University of Wisconsin
- University of Alabama, Birmingham
- Department of Veteran Affairs
- University of Illinois at Chicago
- American Foundation for Suicide Prevention
- Johnson and Johnson
- MercyOne Des Moines Medical Center
Organization Involved with Phase 3 Indications (14)
- NeuroRx, Inc.
- National Institutes of Health (NIH)
- Abarbanel Mental Health Center
- Centre Hospitalier Universitaire de Nīmes
- Tel Aviv University
- University of Cincinnati
- University of Haifa
- Target Health Inc.
- University of Texas at Houston
- University of Texas, Tyler
- University of Nimes
- Bracket Global
- Government of Israel
- Stats Collaborative
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (4)